JD Health International Inc. will hold its Annual General Meeting at 10:00 a.m. on 29 June 2026 at Building A, No. 18 Kechuang 11 Street, Yizhuang Economic and Technological Development Zone, Beijing. Key items on the agenda are as follows:

• Financial Statements: Shareholders will be asked to receive and adopt the audited consolidated financial statements for the year ended 31 December 2025, together with the directors’ and auditor’s reports.

• Board Composition: The meeting will consider the re-election of three directors—Executive Director Dong Cao, Non-Executive Director Richard Qiangdong Liu, and Independent Non-Executive Director Ling Li.

• Director Remuneration: Authority to set director remuneration will be delegated to the board if approved.

• Auditor Appointment: Deloitte Touche Tohmatsu is nominated for re-appointment as auditor until the conclusion of the next AGM, with remuneration to be fixed by the board.

• Share Capital Mandates: – Issuance Mandate: Directors may allot, issue, or deal with shares up to 20% of the company’s issued share capital (excluding treasury shares and repurchased shares pending cancellation) during the mandate period. – Repurchase Mandate: The board may repurchase shares up to 10% of issued share capital on the Stock Exchange or other recognised markets. – Mandate Extension: The issuance mandate may be extended by the aggregate number of shares repurchased under the above 10% authority, capped at an additional 10% of issued shares.

Voting for all resolutions will be conducted by poll. The register of members will be closed from 24 June 2026 to 29 June 2026 (both days inclusive); share transfer documents must be lodged by 4:30 p.m. on 23 June 2026. Proxy forms must be submitted no later than 10:00 a.m. on 27 June 2026.